KEWALRAMANI RESHMA (CEO & President) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2026ACC: 0000875320-26-000070
DirectorOfficer· CEO & President
Since Feb 2026
-13.04K
Net shares
Net seller
$6.36M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.04K
Price / share
$487.76
Trade value
$6.36M
% of position
8.9%
2/13/2026
146.53K→133.49K
Total
Net shares
−13.04K
Net value
-$6.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | F · Tax Withholding | −13.04K | $487.76 | $6.36M | 8.9% | 146.53K | 133.49K |
| Total | −13.04K | -$6.36M | ||||||
Derivative Transactions0
No derivative transactions reported